Liquid glassia - NDC - 00944-2884-01
Ended Awarded Last action
- Contract number
- VA25017J2113
- Awardee
-
Baxalta US Inc. UEI LT5GEHL2F1K6
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $105,560
Award facts
- Contract value 100% obligated
- $105,560.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Deerfield, IL 60015, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $1,560 | |
| Original award | $104,000 |
About this award
This is a federal contract award to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract is a Blanket Purchase Agreement (BPA) call order under Baxalta's existing GSA Schedule 61-IB contract for Pharmaceuticals and Drugs. The awarded contract has a firm-fixed price of $105,560.00 and is for the delivery of the specialty pharmaceutical drug GLASSIA (alpha 1-proteinase inhibitor). The contract has an ultimate completion date of April 15, 2017 and was awarded on February 28, 2017. There is no set-aside designation associated with this contract. Baxalta is a prime contractor providing specialty pharmaceutical products to various federal agencies, including the VA, Department of Health and Human Services, Department of Justice Bureau of Prisons, and Defense Logistics Agency.
Quick answers
Who was awarded contract VA25017J2113?
VA25017J2113 was awarded to Baxalta US Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on February 28, 2017.
How much is contract VA25017J2113 worth?
The government has obligated $105,560 on VA25017J2113.
Is contract VA25017J2113 an order under another contract?
Yes. VA25017J2113 is a BPA call under V797P2140D-VA25017A0009, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA25017J2113 competed?
The extent of competition for VA25017J2113 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award